Tagraxofusp, an Anti-CD123 Therapy, in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm: Sub-Analysis of a Pivotal Trial by Age and Baseline Disease Involvement

被引：0

作者：

Pemmaraju, Naveen ^{[1
]}

Konopleva, Marina ^{[1
]}

Sweet, Kendra ^{[2
]}

Stein, Anthony ^{[3
]}

Vasu, Sumithira ^{[4
]}

Rizzieri, David ^{[5
]}

Wang, Eunice S. ^{[6
]}

Kantarjian, Hagop ^{[1
]}

Brooks, Chris ^{[7
]}

Mughal, Tariq ^{[7
]}

Lane, Andrew ^{[8
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[3] City Hope Natl Med Ctr, Duarte, CA USA

[4] Ohio State Univ, Columbus, OH USA

[5] Duke Univ, Med Ctr, Durham, NC USA

[6] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[7] Stemline Therapeut Inc, New York, NY USA

[8] Dana Farber Canc Inst, Boston, MA USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷

关键词：

AML; myeloid neoplasm; targeted therapy; CD123; tagraxofusp; BPDCN; Phase I/II;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AML-465

引用

页码：S254 / S254

页数：1

共 42 条

[1] Tagraxofusp, an Anti-CD123 Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: Subanalyses of a Pivotal Trial By Age and Baseline Disease Involvement
Pemmaraju, Naveen
Konopleva, Marina
Sweet, Kendra
Stein, Anthony S.
Vasu, Sumithira
Rizzieri, David A.
Wang, Eunice S.
Kantarjian, Hagop
Brooks, Christopher L.
Mughal, Tariq I.
Lane, Andrew A.
BLOOD, 2021, 138
[2] Tagraxofusp, an Anti-CD123 Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm and Prior or Concomitant Hematologic Malignancies: Subgroup Analysis of a Pivotal Trial
Pemmaraju, Naveen
Konopleva, Marina
Sweet, Kendra
Stein, Anthony S.
Vasu, Sumithira
Rizzieri, David A.
Wang, Eunice S.
Kantarjian, Hagop
Brooks, Christopher L.
Paley, Carole
Mughal, Tariq, I
Lane, Andrew A.
BLOOD, 2022, 140 : 6155 - 6157
[3] Tagraxofusp, an Anti-CD123 Therapy, in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm and Prior or Concomitant Hematologic Malignancies: Subgroup Analysis of a Pivotal Trial
Pemmaraju, Naveen
Konopleva, Marina
Sweet, Kendra
Stein, Anthony
Vasu, Sumithira
Rizzieri, David
Wang, Eunice S.
Kantarjian, Hagop
Brooks, Christopher
Mughal, Tariq
Lane, Andrew A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S288 - S288
[4] Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope
Cangini, Delia
Silimbani, Paolo
Cafaro, Alessandro
Giannini, Maria B.
Masini, Carla
Di Rora, Andrea Ghelli Luserna
Simonetti, Giorgia
Martinelli, Giovanni
Cerchione, Claudio
MINERVA MEDICA, 2020, 111 (05) : 467 - 477
[5] TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PEDIATRIC PATIENTS WITH TAGRAXOFUSP, A CD123-TARGETED THERAPY
Vinti, Luciana
Pemmaraju, Naveen
Pawlowska, Anna
Cuglievan, Branko
Lasky, Joseph
Kheradpour, Albert
Hijiya, Nobuko
Stein, Anthony
Meshinchi, Soheil
Mullen, Craig
Mughal, Tariq
Angelucci, Emanuele
PEDIATRIC BLOOD & CANCER, 2022, 69 : S195 - S196
[6] Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm in Pediatric Patients With Tagraxofusp, a CD123Targeted Therapy
Pemmaraju, Naveen
Cuglievan, Branko
Lasky, Joseph
Kheradpour, Albert
Hijiya, Nobuko
Stein, Anthony S.
Meshinchi, Soheil
Mullen, Craig
Angelucci, Emanuele
Vinti, Luciana
Mughal, Tariq I.
Pawlowska, Anna
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S244 - S245
[7] Tagraxofusp, a CD123-Targeted Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Landmark Clinical Trial
Pemmaraju, Naveen
Lane, Andrew
Sweet, Kendra
Stein, Anthony
Vasu, Sumithira
Blum, William
Rizzieri, David
Wang, Eunice
Duvic, Madeleine
Brooks, Christopher
Sloan, J. Mark
Rosenblat, Todd
Akilov, Oleg
Mughal, Tariq
Lancet, Jeffrey
Kantarjian, Hagop
Konopleva, Marina
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S209 - S210
[8] Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in Pediatric Patients with Tagraxofusp, a CD123-Targeted Therapy
Pemmaraju, Naveen
Cuglievan, Branko
Lasky, Joseph L., III
Kheradpour, Albert
Hijiya, Nobuko
Stein, Anthony S.
Pawlowska, Anna B.
BLOOD, 2021, 138
[9] Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
Tianyu Cai
Agnès Gouble
Kathryn L. Black
Anna Skwarska
Ammar S. Naqvi
Deanne Taylor
Ming Zhao
Qi Yuan
Mayumi Sugita
Qi Zhang
Roman Galetto
Stéphanie Filipe
Antonio Cavazos
Lina Han
Vinitha Kuruvilla
Helen Ma
Connie Weng
Chang-Gong Liu
Xiuping Liu
Sergej Konoplev
Jun Gu
Guilin Tang
Xiaoping Su
Gheath Al-Atrash
Stefan Ciurea
Sattva S. Neelapu
Andrew A. Lane
Hagop Kantarjian
Monica L. Guzman
Naveen Pemmaraju
Julianne Smith
Andrei Thomas-Tikhonenko
Marina Konopleva
Nature Communications, 13
[10] Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
Cai, Tianyu
Gouble, Agnes
Black, Kathryn L.
Skwarska, Anna
Naqvi, Ammar S.
Taylor, Deanne
Zhao, Ming
Yuan, Qi
Sugita, Mayumi
Zhang, Qi
Galetto, Roman
Filipe, Stephanie
Cavazos, Antonio
Han, Lina
Kuruvilla, Vinitha
Ma, Helen
Weng, Connie
Liu, Chang-Gong
Liu, Xiuping
Konoplev, Sergej
Gu, Jun
Tang, Guilin
Su, Xiaoping
Al-Atrash, Gheath
Ciurea, Stefan
Neelapu, Sattva S.
Lane, Andrew A.
Kantarjian, Hagop
Guzman, Monica L.
Pemmaraju, Naveen
Smith, Julianne
Thomas-Tikhonenko, Andrei
Konopleva, Marina
NATURE COMMUNICATIONS, 2022, 13 (01)

← 1 2 3 4 5 →